PD Dr. med. Rupert Egensperger

Quach S, Schwartz C, Aumiller M, Foglar M, Schmutzer M, Katzendobler S, El Fahim M, Forbrig R, Bochmann K, Egensperger R, Sroka R, Stepp H, Rühm A & Thon N
Interstitial photodynamic therapy for newly diagnosed glioblastoma.
Journal of neuro-oncology, 2023 Mar, 162 (1) 217-223

Weller J, Katzendobler S, Blobner J, Thiele F, Becker H, Quach S, Egensperger R, Niyazi M, Suchorska B, Thon N, Weller M & Tonn JC
Limited efficacy of temozolomide alone for astrocytoma, IDH-mutant, CNS WHO grades 2 or 3.
Journal of neuro-oncology, 2022 Oct, 160 (1) 149-158

Katzendobler S, Do A, Weller J, Rejeski K, Dorostkar MM, Albert NL, Forbrig R, Niyazi M, Egensperger R, Tonn JC, von Baumgarten L, Quach S & Thon N
The value of stereotactic biopsy of primary and recurrent brain metastases in the era of precision medicine.
Frontiers in oncology, 2022, 12 1014711

Katzendobler S, Do A, Weller J, Dorostkar MM, Albert NL, Forbrig R, Niyazi M, Egensperger R, Thon N, Tonn JC & Quach S
Diagnostic Yield and Complication Rate of Stereotactic Biopsies in Precision Medicine of Gliomas.
Frontiers in neurology, 2022, 13 822362

Biczok A, Karschnia P, Vitalini R, Lenski M, Greve T, Thorsteinsdottir J, Egensperger R, Dorn F, Tonn JC & Schichor C
Past medical history of tumors other than meningioma is a negative prognostic factor for tumor recurrence in meningiomas WHO grade I.
Acta neurochirurgica, 2021 Oct, 163 (10) 2853-2859

Biczok A, Strübing FL, Eder JM, Egensperger R, Schnell O, Zausinger S, Neumann JE, Herms J, Tonn JC & Dorostkar MM
Molecular diagnostics helps to identify distinct subgroups of spinal astrocytomas.
Acta neuropathologica communications, 2021 Jun 30, 9 (1) 119

Weller J, Katzendobler S, Karschnia P, Lietke S, Egensperger R, Thon N, Weller M, Suchorska B & Tonn JC
PCV chemotherapy alone for WHO grade 2 oligodendroglioma: prolonged disease control with low risk of malignant progression.
Journal of neuro-oncology, 2021 Jun, 153 (2) 283-291

Lietke S, Schmutzer M, Schwartz C, Weller J, Siller S, Aumiller M, Heckl C, Forbrig R, Niyazi M, Egensperger R, Stepp H, Sroka R, Tonn JC, Rühm A & Thon N
Interstitial Photodynamic Therapy Using 5-ALA for Malignant Glioma Recurrences.
Cancers, 2021 Apr 07, 13 (8)

Siller S, Egensperger R, Szelenyi A, Tonn JC, Zausinger S & Schichor C
Intraspinal epidermoid and dermoid cysts-tumor resection with multimodal intraoperative neurophysiological monitoring and long-term outcome.
Acta neurochirurgica, 2020 Nov, 162 (11) 2895-2903

Biczok A, Jungk C, Egensperger R, von Deimling A, Suchorska B, Tonn JC, Herold-Mende C & Schichor C
Microscopic brain invasion in meningiomas previously classified as WHO grade I is not associated with patient outcome.
Journal of neuro-oncology, 2019 Dec, 145 (3) 469-477

Kunz M, Albert NL, Unterrainer M, la Fougere C, Egensperger R, Schüller U, Lutz J, Kreth S, Tonn JC, Kreth FW & Thon N
Dynamic 18F-FET PET is a powerful imaging biomarker in gadolinium-negative gliomas.
Neuro-oncology, 2019 Feb 14, 21 (2) 274-284

Mahler C, Unterrainer M, Muth C, Egensperger R, Vomacka L, Lindner S, Ertl-Wagner B, Patzig M, Bartenstein P, Albert N, Kerschensteiner M & Kümpfel T
Imaging microglial activation in tacrolimus-associated CNS vasculitis with translocator protein PET.
Neurology, 2018 Nov 13, 91 (20) 936-937

Romagna A, Schwartz C, Egensperger R, Watson J, Tonn JC, Belka C, Kreth FW & Nachbichler SB
Iodine-125 brachytherapy as upfront and salvage treatment for brain metastases : A comparative analysis.
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2016 Nov, 192 (11) 780-788

Kunz M, Nachbichler SB, Ertl L, Fesl G, Egensperger R, Niyazi M, Schmid I, Tonn JC, Peraud A & Kreth FW
Early treatment of complex located pediatric low-grade gliomas using iodine-125 brachytherapy alone or in combination with microsurgery.
Cancer medicine, 2016 Mar, 5 (3) 442-53

Thon N, Kunz M, Lemke L, Jansen NL, Eigenbrod S, Kreth S, Lutz J, Egensperger R, Giese A, Herms J, Weller M, Kretzschmar H, Tonn JC, la Fougère C & Kreth FW
Dynamic 18F-FET PET in suspected WHO grade II gliomas defines distinct biological subgroups with different clinical courses.
International journal of cancer, 2015 May 01, 136 (9) 2132-45

Eigenbrod S, Trabold R, Brucker D, Erös C, Egensperger R, La Fougere C, Göbel W, Rühm A, Kretzschmar HA, Tonn JC, Herms J, Giese A & Kreth FW
Molecular stereotactic biopsy technique improves diagnostic accuracy and enables personalized treatment strategies in glioma patients.
Acta neurochirurgica, 2014 Aug, 156 (8) 1427-40

Gutenberg A, Nischwitz MD, Gunawan B, Enders C, Jung K, Bergmann M, Feiden W, Egensperger R, Keyvani K, Stolke D, Sure U, Schroeder HW, Warzok R, Schober R, Meixensberger J, Paulus W, Wassmann H, Stummer W, Blumcke I, Buchfelder M, van Landeghem FK, Vajkoczy P, Günther M, Bedke J, Giese A, Rohde V, Brück W, Füzesi L & Sander B
Predictive chromosomal clusters of synchronous and metachronous brain metastases in clear cell renal cell carcinoma.
Cancer genetics, 2014 May, 207 (5) 206-13

Kreth S, Limbeck E, Hinske LC, Schütz SV, Thon N, Hoefig K, Egensperger R & Kreth FW
In human glioblastomas transcript elongation by alternative polyadenylation and miRNA targeting is a potent mechanism of MGMT silencing.
Acta neuropathologica, 2013 May, 125 (5) 671-81

Johansson A, Faber F, Kniebühler G, Stepp H, Sroka R, Egensperger R, Beyer W & Kreth FW
Protoporphyrin IX fluorescence and photobleaching during interstitial photodynamic therapy of malignant gliomas for early treatment prognosis.
Lasers in surgery and medicine, 2013 Apr, 45 (4) 225-34

Jansen NL, Schwartz C, Graute V, Eigenbrod S, Lutz J, Egensperger R, Pöpperl G, Kretzschmar HA, Cumming P, Bartenstein P, Tonn JC, Kreth FW, la Fougère C & Thon N
Prediction of oligodendroglial histology and LOH 1p/19q using dynamic [(18)F]FET-PET imaging in intracranial WHO grade II and III gliomas.
Neuro-oncology, 2012 Dec, 14 (12) 1473-80

Rüb U, Bürk K, Timmann D, den Dunnen W, Seidel K, Farrag K, Brunt E, Heinsen H, Egensperger R, Bornemann A, Schwarzacher S, Korf HW, Schöls L, Bohl J & Deller T
Spinocerebellar ataxia type 1 (SCA1): new pathoanatomical and clinico-pathological insights.
Neuropathology and applied neurobiology, 2012 Dec, 38 (7) 665-80

Schrötter A, Pfeiffer K, El Magraoui F, Platta HW, Erdmann R, Meyer HE, Egensperger R, Marcus K & Müller T
The amyloid precursor protein (APP) family members are key players in S-adenosylmethionine formation by MAT2A and modify BACE1 and PSEN1 gene expression-relevance for Alzheimer's disease.
Molecular & cellular proteomics : MCP, 2012 Nov, 11 (11) 1274-88

Kögel D, Concannon CG, Müller T, König H, Bonner C, Poeschel S, Chang S, Egensperger R & Prehn JH
The APP intracellular domain (AICD) potentiates ER stress-induced apoptosis.
Neurobiology of aging, 2012 Sep, 33 (9) 2200-9

Tennstaedt A, Pöpsel S, Truebestein L, Hauske P, Brockmann A, Schmidt N, Irle I, Sacca B, Niemeyer CM, Brandt R, Ksiezak-Reding H, Tirniceriu AL, Egensperger R, Baldi A, Dehmelt L, Kaiser M, Huber R, Clausen T & Ehrmann M
Human high temperature requirement serine protease A1 (HTRA1) degrades tau protein aggregates.
The Journal of biological chemistry, 2012 Jun 15, 287 (25) 20931-41

Eigenbrod S, Thon N, Jansen N, Janssen H, Mielke J, Ruiter M, la Fougère C, Peraud A, Egensperger R & Kretzschmar H
Intramedullary pilomyxoid astrocytoma with intracerebral metastasis exhibiting oligoden-droglioma-like features.
Rare tumors, 2012 Apr 12, 4 (2) e30

Herold T, Seiler T, Egensperger R, Trumm C, Bergmann M, Franke D, Mumm FF, Schinwald N, Buske C & Dreyling M
Progressive multifocal leukoencephalopathy after treatment with rituximab, fludarabine and cyclophosphamide in a patient with chronic lymphocytic leukemia.
Leukemia & lymphoma, 2012 Jan, 53 (1) 169-72

Eigenbrod S, Roeber S, Thon N, Giese A, Krieger A, Grasbon-Frodl E, Egensperger R, Tonn JC, Kreth FW & Kretzschmar HA
α-Internexin in the diagnosis of oligodendroglial tumors and association with 1p/19q status.
Journal of neuropathology and experimental neurology, 2011 Nov, 70 (11) 970-8

Müller T, Loosse C, Schrötter A, Schnabel A, Helling S, Egensperger R & Marcus K
The AICD interacting protein DAB1 is up-regulated in Alzheimer frontal cortex brain samples and causes deregulation of proteins involved in gene expression changes.
Current Alzheimer research, 2011 Aug, 8 (5) 573-82

Kunz M, Thon N, Eigenbrod S, Hartmann C, Egensperger R, Herms J, Geisler J, la Fougere C, Lutz J, Linn J, Kreth S, von Deimling A, Tonn JC, Kretzschmar HA, Pöpperl G & Kreth FW
Hot spots in dynamic (18)FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas.
Neuro-oncology, 2011 Mar, 13 (3) 307-16

Kreth S, Thon N, Eigenbrod S, Lutz J, Ledderose C, Egensperger R, Tonn JC, Kretzschmar HA, Hinske LC & Kreth FW
O-methylguanine-DNA methyltransferase (MGMT) mRNA expression predicts outcome in malignant glioma independent of MGMT promoter methylation.
PloS one, 2011 Feb 18, 6 (2) e17156

El Hindy N, Adamzik M, Lambertz N, Bachmann HS, Worm K, Egensperger R, Frey UH, Asgari S, Sure U, Siffert W & Sandalcioglu IE
Association of the GNB3 825T-allele with better survival in patients with glioblastoma multiforme.
Journal of cancer research and clinical oncology, 2010 Sep, 136 (9) 1423-9

Yoon MS, Bechmann L, Obermann M, Yepnjouo O, Egensperger R, Gerken G, Katsarava Z, Thomale J & Holtmann G
Recombinant human erythropoietin counteracts cisplatin-induced visceral hyperalgesia.
Neuroscience bulletin, 2010 Aug, 26 (4) 282-8

Kreth S, Heyn J, Grau S, Kretzschmar HA, Egensperger R & Kreth FW
Identification of valid endogenous control genes for determining gene expression in human glioma.
Neuro-oncology, 2010 Jun, 12 (6) 570-9

Grabellus F, Konik MJ, Worm K, Sheu SY, van de Nes JA, Bauer S, Paulus W, Egensperger R & Schmid KW
MET overexpressing chordomas frequently exhibit polysomy of chromosome 7 but no MET activation through sarcoma-specific gene fusions.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2010 Jun, 31 (3) 157-63

Bacher M, Deuster O, Aljabari B, Egensperger R, Neff F, Jessen F, Popp J, Noelker C, Reese JP, Al-Abed Y & Dodel R
The role of macrophage migration inhibitory factor in Alzheimer's disease.
Molecular medicine (Cambridge, Mass.), 2010 Mar, 16 (3-4) 116-21

Albayrak O, Tirniceriu A, Riemenschneider M, Kurz A, Scherag A & Egensperger R
The cathepsin D (224C/T) polymorphism confers an increased risk to develop Alzheimer's disease in men.
The journals of gerontology. Series A, Biological sciences and medical sciences, 2010 Mar, 65 (3) 219-24

Gierga K, Schelhaas HJ, Brunt ER, Seidel K, Scherzed W, Egensperger R, de Vos RA, den Dunnen W, Ippel PF, Petrasch-Parwez E, Deller T, Schöls L & Rüb U
Spinocerebellar ataxia type 6 (SCA6): neurodegeneration goes beyond the known brain predilection sites.
Neuropathology and applied neurobiology, 2009 Oct, 35 (5) 515-27

Yoon MS, Katsarava Z, Obermann M, Schäfers M, Liedert B, Dzagnidze A, Kribben A, Egensperger R, Limmroth V, Diener HC & Thomale J
Erythropoietin overrides the triggering effect of DNA platination products in a mouse model of cisplatin-induced neuropathy.
BMC neuroscience, 2009 Jul 15, 10 77

Jeibmann A, Egensperger R, Kuchelmeister K, Sepehrnia A, Stolke D, Bruns B, Wassmann H, Ebel H, Paulus W & Hasselblatt M
Extent of surgical resection but not myxopapillary versus classical histopathological subtype affects prognosis in lumbo-sacral ependymomas.
Histopathology, 2009 Jan, 54 (2) 260-2

Müller T, Jung K, Ullrich A, Schrötter A, Meyer HE, Stephan C, Egensperger R & Marcus K
Disease state, age, sex, and post-mortem time-dependent expression of proteins in AD vs. control frontal cortex brain samples.
Current Alzheimer research, 2008 Dec, 5 (6) 562-71

Hoche F, Seidel K, Brunt ER, Auburger G, Schöls L, Bürk K, de Vos RA, den Dunnen W, Bechmann I, Egensperger R, Van Broeckhoven C, Gierga K, Deller T & Rüb U
Involvement of the auditory brainstem system in spinocerebellar ataxia type 2 (SCA2), type 3 (SCA3) and type 7 (SCA7).
Neuropathology and applied neurobiology, 2008 Oct, 34 (5) 479-91

Müller T, Meyer HE, Egensperger R & Marcus K
The amyloid precursor protein intracellular domain (AICD) as modulator of gene expression, apoptosis, and cytoskeletal dynamics-relevance for Alzheimer's disease.
Progress in neurobiology, 2008 Aug, 85 (4) 393-406

Riemann K, Adamzik M, Frauenrath S, Egensperger R, Schmid KW, Brockmeyer NH & Siffert W
Comparison of manual and automated nucleic acid extraction from whole-blood samples.
Journal of clinical laboratory analysis, 2007, 21 (4) 244-8

Müller T, Concannon CG, Ward MW, Walsh CM, Tirniceriu AL, Tribl F, Kögel D, Prehn JH & Egensperger R
Modulation of gene expression and cytoskeletal dynamics by the amyloid precursor protein intracellular domain (AICD).
Molecular biology of the cell, 2007 Jan, 18 (1) 201-10

Jeibmann A, Hasselblatt M, Gerss J, Wrede B, Egensperger R, Beschorner R, Hans VH, Rickert CH, Wolff JE & Paulus W
Prognostic implications of atypical histologic features in choroid plexus papilloma.
Journal of neuropathology and experimental neurology, 2006 Nov, 65 (11) 1069-73

Riemenschneider M, Konta L, Friedrich P, Schwarz S, Taddei K, Neff F, Padovani A, Kölsch H, Laws SM, Klopp N, Bickeböller H, Wagenpfeil S, Mueller JC, Rosenberger A, Diehl-Schmid J, Archetti S, Lautenschlager N, Borroni B, Müller U, Illig T, Heun R, Egensperger R, Schlegel J, Förstl H, Martins RN & Kurz A
A functional polymorphism within plasminogen activator urokinase (PLAU) is associated with Alzheimer's disease.
Human molecular genetics, 2006 Aug 15, 15 (16) 2446-56

Banati RB, Egensperger R, Maassen A, Hager G, Kreutzberg GW & Graeber MB
Mitochondria in activated microglia in vitro.
Journal of neurocytology, 2004 Sep, 33 (5) 535-41

Kösel S, Lücking CB, Egensperger R & Graeber MB
Nonradioactive PCR sequencing using digoxigenin.
Methods in molecular biology (Clifton, N.J.), 2003, 226 347-54

Achim C, Auer R, Bergeron C, Cardozo A, Deprez M, de Vos R, Duyckaerts C, Egensperger R, Esiri M, Frosch MP, Giannini C, Goebel HH, Graeber MB, Graham DI, Gray F, Haltia M, Hashizume Y, Ikeda K, Ironside JW, Kreutzberg GW, Lantos P, Lowe J, Ludwin S, Matsumoto Y, Olsson Y, Sasaki A, Scheithauer BW, Takahashi H, Tolnay M, Trojanowski JQ, Troost D & de F Webster H
Global democratic consensus on neuropathological disease criteria.
The Lancet. Neurology, 2002 Oct, 1 (6) 340

Egensperger R, Scheithauer BW, Horvath E, Kovacs K, Giannini C, Young WF, Lloyd R, Atkinson J & Nippoldt TB
Cushing's disease due to plurihormonal adrenocorticotropic hormone and gonadotropin-producing pituitary adenoma.
Acta neuropathologica, 2001 Oct, 102 (4) 398-403

Reusche E, Pilz P, Oberascher G, Lindner B, Egensperger R, Gloeckner K, Trinka E & Iglseder B
Subacute fatal aluminum encephalopathy after reconstructive otoneurosurgery: a case report.
Human pathology, 2001 Oct, 32 (10) 1136-40

von Eitzen U, Kösel S, Grasbon-Frodl EM, Egensperger R & Graeber MB
Sequence analysis of the MTCYB gene in Parkinson disease.
Neurogenetics, 2000 Sep, 3 (1) 47-8

Müller-Vahl KR, Kolbe H, Egensperger R & Dengler R
Mitochondriopathy, blepharospasm, and treatment with botulinum toxin.
Muscle & nerve, 2000 Apr, 23 (4) 647-8

Muller-Vahl KR, Kolbe H, Egensperger R & Dengler R
AAEM news and comments.
Muscle & nerve, 2000 Apr, 23 (4) 651-4

Widjaja A, Mix H, Gölkel C, Flemming P, Egensperger R, Holstein A, Rademaker J, Becker H, Hundt M, Wagner S & Manns MP
Uncommon metastasis of a glioblastoma multiforme in liver and spleen.
Digestion, 2000, 61 (3) 219-22

Bayer TA, Jäkälä P, Hartmann T, Egensperger R, Buslei R, Falkai P & Beyreuther K
Neural expression profile of alpha-synuclein in developing human cortex.
Neuroreport, 1999 Sep 09, 10 (13) 2799-803

Tolnay M, Calhoun M, Pham HC, Egensperger R & Probst A
Low amyloid (Abeta) plaque load and relative predominance of diffuse plaques distinguish argyrophilic grain disease from Alzheimer's disease.
Neuropathology and applied neurobiology, 1999 Aug, 25 (4) 295-305

Egensperger R, Weggen S, Ida N, Multhaup G, Schnabel R, Beyreuther K & Bayer TA
Reverse relationship between beta-amyloid precursor protein and beta-amyloid peptide plaques in Down's syndrome versus sporadic/familial Alzheimer's disease.
Acta neuropathologica, 1999 Feb, 97 (2) 113-8

Grasbon-Frodl EM, Egensperger R, Kösel S, Krüger R, Riess O, Mehraein P & Graeber MB
The alpha1-antichymotrypsin A-allele in German Parkinson disease patients.
Journal of neural transmission (Vienna, Austria : 1996), 1999, 106 (7-8) 729-36

Schramm M, Falkai P, Pietsch T, Neidt I, Egensperger R & Bayer TA
Neural expression profile of Elav-like genes in human brain.
Clinical neuropathology, 1999, 18 (1) 17-22

Tolnay M, Probst A, Monsch AU, Staehelin HB & Egensperger R
Apolipoprotein E allele frequencies in argyrophilic grain disease.
Acta neuropathologica, 1998 Sep, 96 (3) 225-7

Tran CT, Wolz P, Egensperger R, Kösel S, Imai Y, Bise K, Kohsaka S, Mehraein P & Graeber MB
Differential expression of MHC class II molecules by microglia and neoplastic astroglia: relevance for the escape of astrocytoma cells from immune surveillance.
Neuropathology and applied neurobiology, 1998 Aug, 24 (4) 293-301

Egensperger R, Kösel S, von Eitzen U & Graeber MB
Microglial activation in Alzheimer disease: Association with APOE genotype.
Brain pathology (Zurich, Switzerland), 1998 Jul, 8 (3) 439-47

Kösel S, Grasbon-Frodl EM, Mautsch U, Egensperger R, von Eitzen U, Frishman D, Hofmann S, Gerbitz KD, Mehraein P & Graeber MB
Novel mutations of mitochondrial complex I in pathologically proven Parkinson disease.
Neurogenetics, 1998 Mar, 1 (3) 197-204

v Eitzen U, Egensperger R, Kösel S, Grasbon-Frodl EM, Imai Y, Bise K, Kohsaka S, Mehraein P & Graeber MB
Microglia and the development of spongiform change in Creutzfeldt-Jakob disease.
Journal of neuropathology and experimental neurology, 1998 Mar, 57 (3) 246-56

Warzok RW, Kessler C, Apel G, Schwarz A, Egensperger R, Schreiber D, Herbst EW, Wolf E, Walther R & Walker LC
Apolipoprotein E4 promotes incipient Alzheimer pathology in the elderly.
Alzheimer disease and associated disorders, 1998 Mar, 12 (1) 33-9

Egensperger R, Herrmann H, Kösel S & Graeber MB
Association between ACT polymorphism and Alzheimer's disease.
Neurology, 1998 Feb, 50 (2) 575-6

Kösel S, Egensperger R, Bise K, Arbogast S, Mehraein P & Graeber MB
Long-lasting perivascular accumulation of major histocompatibility complex class II-positive lipophages in the spinal cord of stroke patients: possible relevance for the immune privilege of the brain.
Acta neuropathologica, 1997 Dec, 94 (6) 532-8

Bancher C, Egensperger R, Kösel S, Jellinger K & Graeber MB
Low prevalence of apolipoprotein E epsilon 4 allele in the neurofibrillary tangle predominant form of senile dementia.
Acta neuropathologica, 1997 Nov, 94 (5) 403-9

Kösel S, Egensperger R, Schnopp NM & Graeber MB
The 'common deletion' is not increased in parkinsonian substantia nigra as shown by competitive polymerase chain reaction.
Movement disorders : official journal of the Movement Disorder Society, 1997 Sep, 12 (5) 639-45

Egensperger R, Kösel S, Schnopp NM, Mehraein P & Graeber MB
Association of the mitochondrial tRNA(A4336G) mutation with Alzheimer's and Parkinson's diseases.
Neuropathology and applied neurobiology, 1997 Aug, 23 (4) 315-21

Maslim J, Valter K, Egensperger R, Holländer H & Stone J
Tissue oxygen during a critical developmental period controls the death and survival of photoreceptors.
Investigative ophthalmology & visual science, 1997 Aug, 38 (9) 1667-77

Graeber MB, Kösel S, Egensperger R, Banati RB, Müller U, Bise K, Hoff P, Möller HJ, Fujisawa K & Mehraein P
Rediscovery of the case described by Alois Alzheimer in 1911: historical, histological and molecular genetic analysis.
Neurogenetics, 1997 May, 1 (1) 73-80

Kösel S, Egensperger R, von Eitzen U, Mehraein P & Graeber MB
On the question of apoptosis in the parkinsonian substantia nigra.
Acta neuropathologica, 1997 Feb, 93 (2) 105-8

Egensperger R, Maslim J, Bisti S, Holländer H & Stone J
Fate of DNA from retinal cells dying during development: uptake by microglia and macroglia (Müller cells).
Brain research. Developmental brain research, 1996 Nov 22, 97 (1) 1-8

Kurz A, Egensperger R, Haupt M, Lautenschlager N, Romero B, Graeber MB & Müller U
Apolipoprotein E epsilon 4 allele, cognitive decline, and deterioration of everyday performance in Alzheimer's disease.
Neurology, 1996 Aug, 47 (2) 440-3

Egensperger R, Bancher C, Kösel S, Jellinger K, Mehraein P & Graeber MB
The apolipoprotein E epsilon 4 allele in Parkinson's disease with Alzheimer lesions.
Biochemical and biophysical research communications, 1996 Jul 16, 224 (2) 484-6

Kösel S, Lücking CB, Egensperger R, Mehraein P & Graeber MB
Mitochondrial NADH dehydrogenase and CYP2D6 genotypes in Lewy-body parkinsonism.
Journal of neuroscience research, 1996 Apr 15, 44 (2) 174-83

Kösel S, Lücking CB, Egensperger R & Graeber MB
Nonradioactive PCR sequencing using digoxigenin.
Methods in molecular biology (Clifton, N.J.), 1996, 65 81-9

Schnopp NM, Kösel S, Egensperger R & Graeber MB
Regional heterogeneity of mtDNA heteroplasmy in parkinsonian brain.
Clinical neuropathology, 1996, 15 (6) 348-52

Egensperger R, Kösel S, Schnabel R, Mehraein P & Graeber MB
Apolipoprotein E genotype and neuropathological phenotype in two members of a German family with chromosome 14-linked early onset Alzheimer's disease.
Acta neuropathologica, 1995, 90 (3) 257-65

Kurz A, Egensperger R, Lautenschlager N, Haupt M, Altland K, Graeber MB & Müller U
[The apolipoprotein E gene and Alzheimer disease phenotype].
Zeitschrift fur Gerontologie und Geriatrie, 1995, 28 (3) 195-9

Kösel S, Egensperger R, Mehraein P & Graeber MB
No association of mutations at nucleotide 5460 of mitochondrial NADH dehydrogenase with Alzheimer's disease.
Biochemical and biophysical research communications, 1994 Sep 15, 203 (2) 745-9

Holländer H, Egensperger R & Dirlich G
Size distribution of rhodamine-labelled microspheres retrogradely transported in cultured neurons.
Journal of neuroscience methods, 1989 Jul, 29 (1) 1-4

Egensperger R & Holländer H
Electron microscopic visualization of fluorescent microspheres used as a neuronal tracer.
Journal of neuroscience methods, 1988 Apr, 23 (3) 181-6